drugset / Trial / NCT03380793

A Trial to Assess the Efficacy and Safety of Morinidazole in Patients With Appendicitis

NCT03380793

Phase 4 Unknown 614 enrolled Jiangsu Hansoh Pharmaceutical Co., Ltd.
NaSingle-groupOpen-labelTreatment

Summary

To assess the efficacy, safety, tissue distribution of target organ and Population Pharmacokinetic (PPK) of morinidazole and sodium chloride injection with surgery in patients with suppurative or gangrenous appendicitis

Timeline

Start
2016-09
Primary completion
2018-10
Completion
2018-10

Drugs

EvaluationDrugModalityDoseRoute
Subject morinidazole Small molecule 500 mg Intravenous
Background Aztreonam Small molecule
Background etimicin Unknown

Indications